Some of the CEOs with whom we collaborated in 2025
Robert Aleksandrowicz
Robert Aleksandrowicz
Robert Aleksandrowicz
CEO of Cellis
Cellis is developing new class of oncology therapeutics called MDC - Macrophage Drug Conjugates
Shy Zyman
Robert Aleksandrowicz
Robert Aleksandrowicz
CEO of Preci Health
PreciHealth is leading the market of Alternative Blood Collection
.jpg/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:365,h:365,cg:true)
Kim Domela Kjøller
Robert Aleksandrowicz
Kim Domela Kjøller
CEO of Union Therapeutics
Union Therapeutics is a clinical-stage pharmaceutical development company.
Robert Schickel, Ph.D.
Robert Schickel, Ph.D.
Robert Schickel, Ph.D.
CEO of NUAgo Therapeutics
NUAgo Therapeutics is redefining the precision approach in cancer therapeutics.
Cody Simmons
Robert Schickel, Ph.D.
Robert Schickel, Ph.D.
CEO of Derma Sensor
DermaSensor Inc. is a Miami-based connected medical device company that seeks to enable healthcare professionals to efficiently check for skin cancer by leveraging cutting-edge technologies.
Dr. Hitesh Bodani
Robert Schickel, Ph.D.
Dr. Hitesh Bodani
Co-Chairman Board & Business Advisor (London, EU, MENA & Asia)
Dr. Hitesh Bodani, Chairman, is a seasoned and visionary entrepreneur with over two decades of diverse experience across hospitality, real estate, medical technology, and mining sectors. As a board adviser to DON, Hitesh plays a pivotal role in fostering global growth oppor
Co-Chairman Board & Business Advisor (London, EU, MENA & Asia)
Dr. Hitesh Bodani, Chairman, is a seasoned and visionary entrepreneur with over two decades of diverse experience across hospitality, real estate, medical technology, and mining sectors. As a board adviser to DON, Hitesh plays a pivotal role in fostering global growth opportunities and fundraising endeavors, utilizing his extensive network of influential contacts.
Andrew Hall
Andrew Hall
Dr. Hitesh Bodani
CEO of Consano Biologics
Consano Biologics is a biotechnology company focused on developing innovative biologic therapeutics for orthopedic conditions. Their lead product, C-1101, is an Allogenic Multi-Protein Therapeutic (AMPT) aimed at treating painful conditions such as chronic Lumbosacral Radiculopathy.
Murat Croci
Andrew Hall
Murat Croci
CEO of Ibex Biosciences
Ibex Biosciences strives to discover, validate, and produce potential solutions to a multitude of serious challenges facing human health by investing in exploratory projects and processes that may not have been validated within the public research community.
Urs Spitz
Andrew Hall
Murat Croci
Biosynth Member Board of Directors
Urs has a MS in Organic Chemistry and Computer Science from Zürich, and a PhD from Chicago. He then spent time as Postdoctoral Research Fellow at MIT before joining Bain & Co as a consultant. Following this role, Urs became Head of Strategic Business Unit at Mettler Toledo for a number of years.
Since 20
Biosynth Member Board of Directors
Urs has a MS in Organic Chemistry and Computer Science from Zürich, and a PhD from Chicago. He then spent time as Postdoctoral Research Fellow at MIT before joining Bain & Co as a consultant. Following this role, Urs became Head of Strategic Business Unit at Mettler Toledo for a number of years.
Since 2005, Urs has been CEO and President of Biosynth, of which he is a co-owner, and has overseen its continued growth and expansion to a global products and services company.